Clinical Trial: A 12-Week Randomized, Placebo-Controlled Quantitative and Qualitative Evaluation of the Topical Efficacy of Niacinamide Riboside (NR) on Signs of Skin Aging: A Dose Response Comparison in Women Ages 30-60

U.S., Aug. 20 -- ClinicalTrials.gov registry received information related to the study (NCT07774000) titled 'A 12-Week Randomized, Placebo-Controlled Quantitative and Qualitative Evaluation of the Topical Efficacy of Niacinamide Riboside (NR) on Signs of Skin Aging: A Dose Response Comparison in Women Ages 30-60' on Aug. 16.

Brief Summary: Niacinamide riboside (topical NR, also known as nicotinamide riboside) is an endogenous compound and a precursor (building block) to the essential cellular co-enzyme, nicotinamide adenine dinucleotide (NAD+). NAD+ is believed to be involved in more than 500 processes that support and maintain cellular health, including DNA damage repair, cell to cell communication, and the regulation of gene expression. ...